Method and apparatus for gastrointestinal tract ablation to achieve loss of persistent and/or recurrent excess body weight following a weight loss operation
First Claim
1. A method of treating a gastrointestinal tract feature formed by a bariatric surgical procedure that has become dilated comprising:
- identifying a target area of the surgically-formed gastrointestinal feature;
positioning a therapy device in the gastrointestinal tract adjacent to a target area on the dilated feature; and
performing a non-surgical reduction therapy on the target area of the dilated feature.
5 Assignments
0 Petitions
Accused Products
Abstract
Devices and methods are provided for ablational treatment of regions of the digestive tract in post-bariatric surgery patients who fail to achieve or maintain the desired weight loss. Bariatric procedures include Roux-en-Y gastric bypass, biliopancreatic diversion, and sleeve gastrectomy. These procedures reconstruct gastrointestinal tract features, creating pouches, stoma, and tubes that restrict and/or divert the digestive flow. Post-surgical dilation of altered structures is common and diminishes their bariatric effectiveness. Ablation of compromised structures can reduce their size and compliance, restoring bariatric effectiveness. Ablation, as provided the invention, starts at the mucosa and penetrates deeper into the gastrointestinal wall in a controlled manner. Control may also be provided by a fractional ablation that ablates some tissue within a target region and leaves a portion substantially unaffected. Embodiments of the device include an ablational electrode array that spans 360 degrees and an array that spans an arc of less than 360 degrees.
-
Citations
15 Claims
-
1. A method of treating a gastrointestinal tract feature formed by a bariatric surgical procedure that has become dilated comprising:
-
identifying a target area of the surgically-formed gastrointestinal feature; positioning a therapy device in the gastrointestinal tract adjacent to a target area on the dilated feature; and performing a non-surgical reduction therapy on the target area of the dilated feature. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15)
-
Specification